Auto Injectors Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2015-2020 and Forecast 2021-2027

$ PRICE - $ 3,000.00$ 8,900.00

Auto Injectors Market by Type (Fillable, Prefilled), by Technology (Automated, Manual), by Usability (Disposable, Reusable), by Application (Anaphylaxis, Rheumatoid Arthritis, Multiple Sclerosis, Others), by Distribution channel (Hospitals, Retail Pharmacies, Online Pharmacies, Others) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: , Tag:

Report

Description

The global auto injector market size valued 45.4 billion in 2020 and expected to reach USD 109.5 billion by 2027, at a CAGR of 17.6% during the forecast period 2021-2027. Auto Injector is a medical device that is used to self-inject dose of drug, typically life-saving drugs. Auto injector keeps the needle tip covered before to inject and also has a safety mechanism to prevent accidental injection. auto injector market are gaining importance these days to manage the severe conditions like anaphylaxis, rheumatoid arthritis, multiple sclerosis, and others. Most of the auto injectors are single dose and spring loaded syringes. The site of injection depends upon the drug loaded.  Auto-Injectors are easy to use and intended for self-administration by patients or any other care taker or personnel at home. auto injector market manufacturers are diversifying the product portfolio by introducing low-cost auto injector products, incorporate advanced features into products, and with new product launches. For instance, Mylan N.V. introduced generic version of epipen by reducing the price to half of its original product price. Initial pack of two was sold at US$ 600 until December 2016 that will be sold at US$ 300 from January 2017. Bayer AG introduced betaconnect, an electronic auto injector to treat relapsing-remitting multiple sclerosis in 2016. Companies are actively involved in collaborations, and taking license agreements for auto injector’s technology. In September 2016, Aptar Pharma (AptarGroup, Inc.) collaborated with Becton, Dickinson and Company (BD) to develop auto injector using prefillable syringes from BD and Aptar Pharma’s two-step auto-injector technology.

Auto Injectors Market

MARKET SUMMARY
-
17.6% CAGR
  • Study Period– 2021 – 2027
  • Base Year– 2020
  • CAGR– 17.6%
  • Largest Market– North America
  • Fastest Growing Market– Asia-Pacific

Auto Injectors Market

  • The report on global auto injector market gives historical, current and future market sizes (US$ Bn) based on type, technology, usability, distribution channel, application and geographic regions.
  • auto injector market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players

 

  • Sanofi
  • Pfizer, Inc.
  • Mylan N.V.
  • Novartis AG
  • Bayer AG
  • Antares Pharma, Inc.
  • Amgen Inc.
  • Eli Lilly and Company
Auto Injectors Market

Drivers And Restraints

Global auto injectors market is mainly driven by increase in incidence of the life threatening conditions such as anaphylaxis, multiple sclerosis and other food allergies that need an emergency medication. In addition, advancements in auto injectors like introduction of jet injectors, growing home healthcare segment, and increase in demand for the self-injectors expected to bolster the market growth. Furthermore, new formulations, new drug delivery systems, and advancements in targeted drug delivery systems, favourable government policies are expected to boost the auto injectors market. Many biologics are administered as intravenously hence, many manufacturers are adopting auto injectors for the life-saving biologics. However, stringent regulatory requirements, recent product recalls, and presence of substitute products are hampering the global auto injectors market.


North-America got significant share

Auto Injectors Market

Geographically Global Auto Injectors Market segmented into following regions viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America expected to be a major market due to prevalence of anaphylaxis, favourable reimbursement policies and increase in healthcare expenditure. In Europe region, growth of auto injectors market is due to consumers shift from hospital based treatment to home care. Countries like China and India have huge growth potential due to increase in healthcare awareness, expenditure and regulatory initiatives to prevent needle stick injuries. However, various initiatives have been taken by World Health Organization (WHO) and regulatory agencies of the countries globally to create healthcare awareness and accelerate the adoption rate of auto-injectors in the Asia-Pacific region. The Middle East and Africa auto injectors market is expected to gain lucrative growth owing to increase in incidences of anaphylaxis and needle stick injuries due to poor healthcare practices in countries like South Africa.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Notable Market Developments


Key

Report Outline

Auto Injectors Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content

Description

The global auto injector market size valued 45.4 billion in 2020 and expected to reach USD 109.5 billion by 2027, at a CAGR of 17.6% during the forecast period 2021-2027. Auto Injector is a medical device that is used to self-inject dose of drug, typically life-saving drugs. Auto injector keeps the needle tip covered before to inject and also has a safety mechanism to prevent accidental injection. auto injector market are gaining importance these days to manage the severe conditions like anaphylaxis, rheumatoid arthritis, multiple sclerosis, and others. Most of the auto injectors are single dose and spring loaded syringes. The site of injection depends upon the drug loaded.  Auto-Injectors are easy to use and intended for self-administration by patients or any other care taker or personnel at home. auto injector market manufacturers are diversifying the product portfolio by introducing low-cost auto injector products, incorporate advanced features into products, and with new product launches. For instance, Mylan N.V. introduced generic version of epipen by reducing the price to half of its original product price. Initial pack of two was sold at US$ 600 until December 2016 that will be sold at US$ 300 from January 2017. Bayer AG introduced betaconnect, an electronic auto injector to treat relapsing-remitting multiple sclerosis in 2016. Companies are actively involved in collaborations, and taking license agreements for auto injector’s technology. In September 2016, Aptar Pharma (AptarGroup, Inc.) collaborated with Becton, Dickinson and Company (BD) to develop auto injector using prefillable syringes from BD and Aptar Pharma’s two-step auto-injector technology.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX